![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 21, 14823-14830, May 21, 1999
B
,
,
,
,
,
, and
From the The last step in the activation of the
transcription factor NF-
Department of Biochemistry and the Rappaport
Family Institute for Research in the Medical Sciences, Bruce Rappaport
Faculty of Medicine, Haifa 31096, Israel, the ¶ Department of
Pathology and the Kaplan Comprehensive Cancer Center, New York
University Medical Center, New York, New York 10016, and the
Department of Immunology and Cell Biology, Graduate School of
Medicine, Kyoto University, Sankyo-ku, Kyoto 606-8501, Japan
B is signal-induced, ubiquitin- and
proteasome-mediated degradation of the inhibitor I
B
. Although
most of the components involved in the activation and degradation
pathways have been identified, the ubiquitin carrier proteins (E2) have
remained elusive. Here we show that the two highly homologous members
of the UBCH5 family, UBCH5b and UBCH5c, and CDC34/UBC3, the mammalian
homolog of yeast Cdc34/Ubc3, are the E2 enzymes involved in the
process. The conjugation reaction they catalyze in vitro is
specific, as they do not recognize the S32A,S36A mutant species of
I
B
that cannot be phosphorylated and conjugated following an
extracellular signal. Furthermore, the reaction is specifically
inhibited by a doubly phosphorylated peptide that spans the ubiquitin
ligase recognition domain of the inhibitor. Cys-to-Ala mutant species
of the enzymes that cannot bind ubiquitin inhibit tumor necrosis factor
-induced degradation of the inhibitor in vivo. Not
surprisingly, they have a similar effect in a cell-free system as well.
Although it is clear that the E2 enzymes are not entirely specific to
I
B
, they are also not involved in the conjugation and degradation
of the bulk of cellular proteins, thus exhibiting some degree of
specificity that is mediated probably via their association with a
defined subset of ubiquitin-protein ligases. The mechanisms that
underlie the involvement of two different E2 species in I
B
conjugation are not clear at present. It is possible that different
conjugating machineries operate under different physiological
conditions or in different cells.
This article has been cited by other articles:
![]() |
X. Zhang, J. Zhou, A. F. Fernandes, J. R. Sparrow, P. Pereira, A. Taylor, and F. Shang The Proteasome: A Target of Oxidative Damage in Cultured Human Retina Pigment Epithelial Cells Invest. Ophthalmol. Vis. Sci., August 1, 2008; 49(8): 3622 - 3630. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Grou, A. F. Carvalho, M. P. Pinto, S. Wiese, H. Piechura, H. E. Meyer, B. Warscheid, C. Sa-Miranda, and J. E. Azevedo Members of the E2D (UbcH5) Family Mediate the Ubiquitination of the Conserved Cysteine of Pex5p, the Peroxisomal Import Receptor J. Biol. Chem., May 23, 2008; 283(21): 14190 - 14197. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zhou, L. A. Dada, N. S. Chandel, K. Iwai, E. Lecuona, A. Ciechanover, and J. I. Sznajder Hypoxia-mediated Na-K-ATPase degradation requires von Hippel Lindau protein FASEB J, May 1, 2008; 22(5): 1335 - 1342. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Kelly, J. K. VanSlyke, and L. S. Musil Regulation of Ubiquitin-Proteasome System mediated Degradation by Cytosolic Stress Mol. Biol. Cell, November 1, 2007; 18(11): 4279 - 4291. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Collado, V. Garcia, J. M. Garcia, I. Alonso, L. Lombardia, R. Diaz-Uriarte, L. A. Lopez Fernandez, A. Zaballos, F. Bonilla, and M. Serrano Genomic Profiling of Circulating Plasma RNA for the Analysis of Cancer Clin. Chem., October 1, 2007; 53(10): 1860 - 1863. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ferrand, C. Demange, C. Prunier, S. R. Seo, and A. Atfi A mechanism for mutational inactivation of the homeodomain protein TGIF in holoprosencephaly FASEB J, February 1, 2007; 21(2): 488 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mijatovic, A. Op De Beeck, E. Van Quaquebeke, J. Dewelle, F. Darro, Y. de Launoit, and R. Kiss The cardenolide UNBS1450 is able to deactivate nuclear factor {kappa}B-mediated cytoprotective effects in human non-small cell lung cancer cells. Mol. Cancer Ther., February 1, 2006; 5(2): 391 - 399. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Lee, K. Perrem, J. W. Harper, K. P. Lu, and X. Z. Zhou The F-box Protein FBX4 Targets PIN2/TRF1 for Ubiquitin-mediated Degradation and Regulates Telomere Maintenance J. Biol. Chem., January 13, 2006; 281(2): 759 - 768. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Saville, A. Sparks, D. P. Xirodimas, J. Wardrop, L. F. Stevenson, J.-C. Bourdon, Y. L. Woods, and D. P. Lane Regulation of p53 by the Ubiquitin-conjugating Enzymes UbcH5B/C in Vivo J. Biol. Chem., October 1, 2004; 279(40): 42169 - 42181. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Xu, M. Farah, J. M. Webster, and R. J.H. Wojcikiewicz Bortezomib rapidly suppresses ubiquitin thiolesterification to ubiquitin-conjugating enzymes and inhibits ubiquitination of histones and type I inositol 1,4,5-trisphosphate receptor Mol. Cancer Ther., October 1, 2004; 3(10): 1263 - 1269. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kudo, D. Guardavaccaro, P. G. Santamaria, R. Koyama-Nasu, E. Latres, R. Bronson, L. Yamasaki, and M. Pagano Role of F-Box Protein {beta}Trcp1 in Mammary Gland Development and Tumorigenesis Mol. Cell. Biol., September 15, 2004; 24(18): 8184 - 8194. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cohen, H. Achbert-Weiner, and A. Ciechanover Dual Effects of I{kappa}B Kinase {beta}-Mediated Phosphorylation on p105 Fate: SCF{beta}-TrCP-Dependent Degradation and SCF{beta}-TrCP-Independent Processing Mol. Cell. Biol., January 1, 2004; 24(1): 475 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Webster, S. Tiwari, A. M. Weissman, and R. J. H. Wojcikiewicz Inositol 1,4,5-Trisphosphate Receptor Ubiquitination Is Mediated by Mammalian Ubc7, a Component of the Endoplasmic Reticulum-associated Degradation Pathway, and Is Inhibited by Chelation of Intracellular Zn2+ J. Biol. Chem., October 3, 2003; 278(40): 38238 - 38246. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. WANAMAKER, J. C. CHRISTIANSON, and W. N. GREEN Regulation of Nicotinic Acetylcholine Receptor Assembly Ann. N.Y. Acad. Sci., September 1, 2003; 998(1): 66 - 80. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Dumont, F. Lallemand, C. Prunier, N. Ferrand, A. Guillouzo, B. Clement, A. Atfi, and N. Theret Evidence for a Role of Smad3 and Smad2 in Stabilization of the Tumor-derived Mutant Smad2.Q407R J. Biol. Chem., June 27, 2003; 278(27): 24881 - 24887. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Amir, K. Iwai, and A. Ciechanover The NEDD8 Pathway Is Essential for SCFbeta -TrCP-mediated Ubiquitination and Processing of the NF-kappa B Precursor p105 J. Biol. Chem., June 21, 2002; 277(26): 23253 - 23259. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Swinney, Y.-Z. Xu, L. E. Scarafia, I. Lee, A. Y. Mak, Q.-F. Gan, C. S. Ramesha, M. A. Mulkins, J. Dunn, O.-Y. So, et al. A Small Molecule Ubiquitination Inhibitor Blocks NF-kappa B-dependent Cytokine Expression in Cells and Rats J. Biol. Chem., June 21, 2002; 277(26): 23573 - 23581. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Glickman and A. Ciechanover The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction Physiol Rev, April 1, 2002; 82(2): 373 - 428. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Hagglund, C. Van Sant, P. Lopez, and B. Roizman Herpes simplex virus 1-infected cell protein 0 contains two E3 ubiquitin ligase sites specific for different E2 ubiquitin-conjugating enzymes PNAS, January 22, 2002; 99(2): 631 - 636. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Stroschein, S. Bonni, J. L. Wrana, and K. Luo Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN Genes & Dev., November 1, 2001; 15(21): 2822 - 2836. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Vogt Sionov, S. Coen, Z. Goldberg, M. Berger, B. Bercovich, Y. Ben-Neriah, A. Ciechanover, and Y. Haupt c-Abl Regulates p53 Levels under Normal and Stress Conditions by Preventing Its Nuclear Export and Ubiquitination Mol. Cell. Biol., September 1, 2001; 21(17): 5869 - 5878. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xu and L. Attisano Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway PNAS, April 25, 2000; 97(9): 4820 - 4825. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Read, J. E. Brownell, T. B. Gladysheva, M. Hottelet, L. A. Parent, M. B. Coggins, J. W. Pierce, V. N. Podust, R.-S. Luo, V. Chau, et al. Nedd8 Modification of Cul-1 Activates SCFbeta TrCP-Dependent Ubiquitination of Ikappa Balpha Mol. Cell. Biol., April 1, 2000; 20(7): 2326 - 2333. [Abstract] [Full Text] |
||||
![]() |
K. Wu, S. Y. Fuchs, A. Chen, P. Tan, C. Gomez, Z.'e. Ronai, and Z.-Q. Pan The SCFHOS/beta -TRCP-ROC1 E3 Ubiquitin Ligase Utilizes Two Distinct Domains within CUL1 for Substrate Targeting and Ubiquitin Ligation Mol. Cell. Biol., February 15, 2000; 20(4): 1382 - 1393. [Abstract] [Full Text] |
||||
![]() |
H. Bastians, L. M. Topper, G. L. Gorbsky, and J. V. Ruderman Cell Cycle-regulated Proteolysis of Mitotic Target Proteins Mol. Biol. Cell, November 1, 1999; 10(11): 3927 - 3941. [Abstract] [Full Text] |
||||
![]() |
K. Iwai, K. Yamanaka, T. Kamura, N. Minato, R. C. Conaway, J. W. Conaway, R. D. Klausner, and A. Pause Identification of the von Hippel-Lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex PNAS, October 26, 1999; 96(22): 12436 - 12441. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |